Alexis A, Anders K, Seetasith A, Holden M. Comparison of Study Designs for Primary Phase III Trials for Omalizumab Versus Dupilumab for Patients With Chronic Spontaneous Urticaria. J of Skin [Internet]. 2024 Jan. 16 [cited 2024 Jul. 3];8(1):s333. Available from: https://jofskin.org/33014/index.php/skin/article/view/2550